We are live on
!
Find out more
Rockefeller Capital Management Portfolio holdings
AUM
$56.4B
1-Year Est. Return
24.96%
This Fund
S&P 500
This Quarter
Est. Return
+16.85%
1 Year Est. Return
+24.96%
3 Year Est. Return
+83.53%
5 Year Est. Return
+100.91%
10 Year Est. Return
–
AUM
$13.2B
AUM Growth
+$2.53B
(+24%)
Cap. Flow
+$1B
Cap. Flow
% of AUM
7.59%
Top 10 Holdings %
Top 10 Hldgs %
23.93%
Holding
3,118
New
401
Increased
1,400
Reduced
617
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$120M |
| 2 |
Globe Life
GL
|
+$115M |
| 3 |
MPT
Medical Properties Trust
MPT
|
+$91.5M |
| 4 |
Arch Capital
ACGL
|
+$69.2M |
| 5 |
Amazon
AMZN
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$138M |
| 2 |
GSK
GSK
|
+$98.7M |
| 3 |
Crown Holdings
CCK
|
+$92.3M |
| 4 |
American Water Works
AWK
|
+$54M |
| 5 |
SolarEdge
SEDG
|
+$45.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.64% |
| 2 | Financials | 15.05% |
| 3 | Healthcare | 13.07% |
| 4 | Consumer Discretionary | 9.61% |
| 5 | Communication Services | 7.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
701
Ingredion
INGR
$6.58B
| $964K | 0.01% |
12,261
+7,957
| +185% | +$614K |
|
702
Q2 Holdings
QTWO
$3.92B
| $961K | 0.01% |
+7,600
| New | +$819K |
|
703
Arista Networks
ANET
$238B
| $958K | 0.01% |
52,800
+16,336
| +45% | +$259K |
|
|
CTXS
704
DELISTED
Citrix Systems Inc
CTXS
| $949K | 0.01% |
7,302
+284
| +4% | +$36.1K |
|
705
Grupo Aeroportuario del Sureste
ASR
$8.3B
| $945K | 0.01% |
+5,732
| New | +$803K |
|
706
First Trust Senior Loan Fund ETF
FTSL
$2.33B
| $945K | 0.01% |
19,877
+649
| +3% | +$30.3K |
|
|
NFJ
707
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.43B
| $941K | 0.01% |
69,965
+3,565
| +5% | +$44.9K |
|
708
Liberty Broadband Class C
LBRDK
$5.15B
| $934K | 0.01% |
5,900
+1,357
| +30% | +$206K |
|
709
Snap
SNAP
$9.01B
| $934K | 0.01% |
18,655
+627
| +3% | +$26K |
|
710
Janus Henderson Mortgage-Backed Securities ETF
JMBS
$6.75B
| $930K | 0.01% |
17,410
+1,138
| +7% | +$61K |
|
|
SIVB
711
DELISTED
SVB Financial Group
SIVB
| $930K | 0.01% |
2,400
-435
| -15% | -$141K |
|
712
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.2B
| $926K | 0.01% |
7,785
+394
| +5% | +$44.1K |
|
713
United Airlines
UAL
$42.1B
| $917K | 0.01% |
21,221
+1,044
| +5% | +$42.2K |
|
714
Virgin Galactic
SPCE
$398M
| $916K | 0.01% |
1,931
+782
| +68% | +$365K |
|
715
Cognizant
CTSH
$26B
| $911K | 0.01% |
11,134
+3,946
| +55% | +$300K |
|
716
PENN Entertainment
PENN
$2.71B
| $911K | 0.01% |
10,550
+1,426
| +16% | +$102K |
|
717
State Street DoubleLine Total Return Tactical ETF
TOTL
$4B
| $905K | 0.01% |
18,376
-950
| -5% | -$46.9K |
|
718
HCA Healthcare
HCA
$89.5B
| $902K | 0.01% |
5,488
-1,472
| -21% | -$215K |
|
719
Take-Two Interactive
TTWO
$46.1B
| $896K | 0.01% |
4,316
+1,020
| +31% | +$178K |
|
720
Rexford Industrial Realty
REXR
$8.19B
| $895K | 0.01% |
18,250
-8,557
| -32% | -$417K |
|
721
CRISPR Therapeutics
CRSP
$5.17B
| $893K | 0.01% |
5,838
+1,321
| +29% | +$156K |
|
722
Gabelli Equity Trust
GAB
$1.79B
| $892K | 0.01% |
145,670
-12,443
| -8% | -$71.7K |
|
723
MPLX
MPLX
$59.7B
| $892K | 0.01% |
41,260
-1,852
| -4% | -$36.5K |
|
724
iShares Core S&P US Growth ETF
IUSG
$33.9B
| $890K | 0.01% |
10,041
+633
| +7% | +$53.3K |
|
725
Molina Healthcare
MOH
$10.3B
| $881K | 0.01% |
4,148
+176
| +4% | +$36.3K |
|
Similar funds
NAMI
Rockefeller Capital Management's Q4 2020 Portfolio in Review
As of Q4 2020, Rockefeller Capital Management held 3,118 positions worth $13.2B, up 24% from $10.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Rockefeller Capital Management deployed $1B of net new capital in Q4 2020, opening 401 new positions and adding to 1,400 existing holdings. Its largest new stake was BridgeBio Pharma: 777,031 shares worth $55.3M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 21% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Progressive, an estimated $138M trimmed.
- Rockefeller Capital Management's largest Q4 2020 buy was BridgeBio Pharma: 777,031 shares worth $55.3M.
- Rockefeller Capital Management added most to Alibaba in Q4 2020, an estimated $120M increase.
- Rockefeller Capital Management's biggest Q4 2020 reduction was Progressive, cutting an estimated $138M.
- Rockefeller Capital Management fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $1.67M.
- Rockefeller Capital Management's ten largest holdings make up 24% of its $13.2B portfolio in Q4 2020.
- Rockefeller Capital Management opened 401 new positions and closed 168 in Q4 2020.
- Rockefeller Capital Management's portfolio value rose 24% quarter-over-quarter to $13.2B.
Based on Rockefeller Capital Management's 13F filing for Q4 2020, filed 12 Feb 2021.